StockData
Anbio Biotechnology logo

Anbio Biotechnology (NNNN) stock

NNNNNasdaqIn Vitro & In Vivo Diagnostic SubstancesFiscal year ends December 31
Financials through fiscal 2025, year ended Dec 31, 2025Last filing: 20-F on Apr 7, 2026Score 11/30
$3.32−0.33 (-9.04%)

Close on Nov 20, 2026Market cap $477.72MP/E 22.6Yield –

Anbio Biotechnology gross profit

Gross profit is revenue minus the direct cost of the goods and services sold.

For fiscal 2025 it was $7.54M, up 28.2% from the year before.

Annual gross profit

PeriodPeriod endValueChange
FY2025Dec 31, 2025$7.54M+28.2%
FY2024Dec 31, 2024$5.89M+75.1%
FY2023Dec 31, 2023$3.36M-73.2%
FY2022Dec 31, 2022$12.56M–

More Anbio Biotechnology figures

See a number that looks wrong?